Assignee
BIOMED VALLEY DISCOVERIES INC
US·33 granted patents·11 pending applications·50 citations·filing 2012–2025
Top patents by PatentIndex Score
44 records- 0194US9861621B2LPT-723 and immune checkpoint inhibitor combinations and methods of treatmentBIOMED VALLEY DISCOVERIES INC·Filed 2016·Granted Jan 9, 2018·16 cites·67 claims
- 0293US9676746B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2016·Granted Jun 13, 2017·6 cites·82 claims
- 0387US11246859B2Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Feb 15, 2022·2 cites·3 claims
- 0487US10881646B2Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Jan 5, 2021·2 cites·12 claims
- 0586US10758614B2Combination therapies targeting tumor-associated stroma or tumor cells and topoisomeraseBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·3 cites·10 claims
- 0686US2025084059A1CRYSTALLINE FORMS OF C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2024·Application pending·0 cites
- 0785US2024374604A1Cancer treatments using combinations of cdk and erk inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2024·Application pending·0 cites
- 0884US12076324B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2023·Granted Sep 3, 2024·0 cites·24 claims
- 0984US10485796B2LPT-723 and immune checkpoint inhibitor combinations and methods of treatmentBIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Nov 26, 2019·3 cites·14 claims
- 1083US11007184B2Cancer treatments using combinations of type 2 MEK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted May 18, 2021·3 cites·33 claims
- 1183US10668055B2Cancer treatment using combinations of ERK and RAF inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted Jun 2, 2020·3 cites·27 claims
- 1282US10183927B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Jan 22, 2019·2 cites·26 claims
- 1382US9951041B2Crystalline C21H22Cl2N4O2 malonateBIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Apr 24, 2018·3 cites·11 claims
- 1482US9670177B2Crystalline C21H22Cl2N4O2 malonateBIOMED VALLEY DISCOVERIES INC·Filed 2016·Granted Jun 6, 2017·3 cites·22 claims
- 1580US12187698B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2022·Granted Jan 7, 2025·0 cites·10 claims
- 1678US10716782B2LPT-723 and immune checkpoint inhibitor combinations and methods of treatmentBIOMED VALLEY DISCOVERIES INC·Filed 2019·Granted Jul 21, 2020·1 cites·20 claims
- 1777US11007183B2Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted May 18, 2021·1 cites·22 claims
- 1877US10617723B2C. novyi for the treatment of solid tumors in humansBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted Apr 14, 2020·1 cites·45 claims
- 1976US11679112B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2021·Granted Jun 20, 2023·0 cites·50 claims
- 2075US2026000714A1C. novyi for the treatment of solid tumors in non-human animalsBIOMED VALLEY DISCOVERIES INC·Filed 2025·Application pending·0 cites
- 2174US2022378852A1C. novyi for the treatment of solid tumors in humansBIOMED VALLEY DISCOVERIES INC·Filed 2022·Application pending·0 cites
- 2273US11013743B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted May 25, 2021·0 cites·33 claims
- 2373US10738027B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2018·Granted Aug 11, 2020·0 cites·10 claims
- 2473US9757424B2Compositions and methods of treating gliomasBIOMED VALLEY DISCOVERIES INC·Filed 2012·Granted Sep 12, 2017·1 cites·8 claims
- 2572US11390600B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Jul 19, 2022·0 cites·10 claims
- 2671US11135225B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Oct 5, 2021·0 cites·22 claims
- 2771US11033537B2LPT-723 and immune checkpoint inhibitor combinations and methods of treatmentBIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Jun 15, 2021·0 cites·35 claims
- 2871US2021038587A1Methods and compositions for treating non-erk mapk pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2020·Application pending·0 cites
- 2970US11439669B2C. novyi for the treatment of solid tumors in humansBIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Sep 13, 2022·0 cites·45 claims
- 3068US12433920B2C. novyi for the treatment of solid tumors in non-human animalsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted Oct 7, 2025·0 cites·39 claims
- 3159US2025026733A1Deuterated analogs of pyrole inhibitors of erk, synthesis thereof and intermediates theretoBIOMED VALLEY DISCOVERIES INC·Filed 2024·Application pending·0 cites
- 3254US12582635B2Compositions and methods for treating cancer with atypical BRAF mutationsBIOMED VALLEY DISCOVERIES INC·Filed 2018·Granted Mar 24, 2026·0 cites·30 claims
- 3353US2016317519A1Methods and compositions for treating non-erk mapk pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2016·Application pending·0 cites
- 3447US2014228248A1Methods and compositions for detecting infectionsBIOMED VALLEY DISCOVERIES INC·Filed 2012·Application pending·0 cites
- 3547US2016145355A1Bispecific antibodiesBIOMED VALLEY DISCOVERIES INC·Filed 2014·Application pending·0 cites
- 3645US10799584B2Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agentsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Oct 13, 2020·0 cites·6 claims
- 3745US2016310477A1Cancer treatments using combinations of mek type 1 and erk inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Application pending·0 cites
- 3844US11033620B2Combination therapies targeting tumor-associated stroma or tumor cells and microtubulesBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·13 claims
- 3944US10758613B2Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·0 cites·11 claims
- 4043US11034757B2Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculatureBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·6 claims
- 4142US10758526B2Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathwaysBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·0 cites·11 claims
- 4240US11033621B2Combination therapies targeting tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·12 claims
- 4339US10434174B2Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Oct 8, 2019·0 cites·37 claims
- 4438US2017114133A1Tem8 antibodies and methods of useBIOMED VALLEY DISCOVERIES INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIOMED VALLEY DISCOVERIES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →